Scarica l'app Stockscreener
2.24
2.28%
0.05
Pre-mercato:
2.26
0.02
+0.89%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMEA Giù?
Forum
Previsione
Precedente Chiudi:
$2.19
Aprire:
$2.3
Volume 24 ore:
431.35K
Relative Volume:
0.68
Capitalizzazione di mercato:
$64.62M
Reddito:
-
Utile/perdita netta:
$-144.01M
Rapporto P/E:
-0.5586
EPS:
-4.01
Flusso di cassa netto:
$-113.02M
1 W Prestazione:
+30.23%
1M Prestazione:
-2.61%
6M Prestazione:
-81.95%
1 anno Prestazione:
-79.22%
Intervallo 1D:
$2.125
$2.30
Intervallo di 1 settimana:
$1.73
$2.41
Portata 52W:
$1.53
$13.43
Biomea Fusion Inc Stock (BMEA) Company Profile
Nome
Biomea Fusion Inc
Settore
Industria
Telefono
(650) 980-9099
Indirizzo
900 MIDDLEFIELD ROAD, REDWOOD CITY
Confronta BMEA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
2.24 | 64.62M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.49 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.86 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.97 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.46 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-09 | Iniziato | Edward Jones | Buy |
| 2024-09-27 | Aggiornamento | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | Aggiornamento | Truist | Hold → Buy |
| 2024-08-29 | Iniziato | CapitalOne | Overweight |
| 2024-06-11 | Downgrade | Truist | Buy → Hold |
| 2024-06-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-04-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-06 | Iniziato | Truist | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2023-05-12 | Iniziato | Barclays | Overweight |
| 2023-03-29 | Reiterato | Oppenheimer | Outperform |
| 2023-03-28 | Reiterato | H.C. Wainwright | Buy |
| 2023-02-24 | Iniziato | Citigroup | Buy |
| 2022-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2022-01-12 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-17 | Iniziato | Oppenheimer | Outperform |
| 2021-05-11 | Iniziato | JP Morgan | Overweight |
| 2021-05-11 | Iniziato | Jefferies | Buy |
| 2021-05-11 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Biomea Fusion Inc Borsa (BMEA) Ultime notizie
Press Release Distribution & PR Platform - ACCESS Newswire
Biomea Fusion (BMEA) Projected to Post Earnings on Thursday - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by Alliancebernstein L.P. - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of “Buy” from Analysts - American Banking and Market News
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Wellington Management Group LLP Invests $317,000 in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Reviewing Biomea Fusion (NASDAQ:BMEA) and Tango Therapeutics (NASDAQ:TNGX) - Defense World
Biomea Fusion’s SWOT analysis: diabetes drug progress lifts stock outlook By Investing.com - Investing.com Australia
Biomea Fusion's SWOT analysis: diabetes drug progress lifts stock outlook - Investing.com
Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline - Investing.com Canada
IVEY PMI Reading Due Next Week in Canada - The Globe and Mail
Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline By Investing.com - Investing.com South Africa
HC Wainwright Reduces Earnings Estimates for Biomea Fusion - Defense World
Barclays Issues Pessimistic Forecast for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Biomea Fusion, Inc. (BMEA) - ACCESS Newswire
HC Wainwright Weighs in on Biomea Fusion Q1 Earnings - Defense World
After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biomea Fusion’s Strategic Shift: A Year of Transformation - TipRanks
Biomea Fusion, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Biomea Fusion Expands Team with Strategic Equity Compensation Package - Stock Titan
After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Biomea Fusion Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Biomea Fusion (NASDAQ:BMEA) Receives “Buy” Rating from HC Wainwright - Defense World
Scotiabank Keeps Their Buy Rating on Biomea Fusion (BMEA) - The Globe and Mail
Biomea Fusion reports Q4 EPS (81c), consensus (93c) - TipRanks
Biomea Fusion, Inc. SEC 10-K Report - TradingView
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - The Manila Times
Breakthrough: Biomea's Diabetes Treatment Achieves Major Blood Sugar Control Milestone - Stock Titan
After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Virtu Financial LLC Makes New Investment in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Biomea Fusion (BMEA) to Release Earnings on Monday - Defense World
BIOMEA FUSION Earnings Preview: Recent $BMEA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Biomea Fusion Inc expected to post a loss of 92 cents a shareEarnings Preview - TradingView
Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline By Investing.com - Investing.com South Africa
Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline - Investing.com Australia
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of “Buy” by Brokerages - Defense World
Thomas Butler steps down as Biomea CEO - BioCentury
Biomea Fusion Appoints Michael Hitchcock Interim CEO - MarketScreener
Biomea Fusion Inc Azioni (BMEA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):